CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- Open-market buys, last 90 days
- $10,726,255
- in 1 filing
- Open-market sales, last 90 days
- $1,037,650
- in 7 filings
Net +$9,688,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- AKKARAJU SRINIVAS +$9.7M Director sold 4% of stake
- Schroer John R. −$5K Chief Financial Officer sold 3% of stake
- Hardiman Roy C. −$4K Chief Business & Strategy Ofcr sold <1% of stake
- Goldstein David M −$4K Chief Scientific Officer sold 2% of stake
- Bradley Mark Christopher −$4K Chief Development Officer sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-08 | Tananbaum James B. Director | Purchase | +294,117 | $17.00 | $5.0M | 2,908,332 |
| 2025-12-05 | AKKARAJU SRINIVAS Director | Purchase | +64,969 | $8.95 | $581K | 1,143,845 |
| 2025-12-05 | AKKARAJU SRINIVAS Director | Purchase | +70,028 | $10.01 | $701K | 1,213,873 |
| 2025-12-05 | AKKARAJU SRINIVAS Director | Purchase | +51,380 | $10.73 | $551K | 1,265,253 |
| 2025-12-04 | AKKARAJU SRINIVAS Director | Purchase | +66,027 | $8.18 | $540K | 1,078,876 |
| 2025-12-03 | AKKARAJU SRINIVAS Director | Purchase | +100,000 | $7.75 | $775K | 1,012,849 |
| 2025-12-02 | AKKARAJU SRINIVAS Director | Purchase | +96,000 | $7.55 | $725K | 912,849 |
| 2025-12-01 | AKKARAJU SRINIVAS Director | Purchase | +86,350 | $7.46 | $644K | 816,849 |
| 2025-11-28 | AKKARAJU SRINIVAS Director | Purchase | +38,702 | $7.64 | $296K | 730,499 |
| 2025-11-26 | AKKARAJU SRINIVAS Director | Purchase | +48,537 | $7.64 | $371K | 691,797 |
| 2025-11-21 | Foresite Capital Management VI LLC 10% owner | Purchase | +72,212 | $7.38 | $533K | 2,614,215 |
| 2025-11-21 | Tananbaum James B. Director | Purchase | +72,212 | $7.38 | $533K | 2,614,215 |
| 2025-11-21 | Foresite Labs, LLC 10% owner | Purchase | +72,212 | $7.38 | $533K | 2,614,215 |
| 2025-11-20 | AKKARAJU SRINIVAS Director | Purchase | +125,743 | $7.20 | $905K | 643,260 |
| 2025-11-19 | AKKARAJU SRINIVAS Director | Purchase | +137,772 | $6.56 | $904K | 517,517 |
| 2025-11-19 | Foresite Labs, LLC 10% owner | Purchase | +190,500 | $6.56 | $1.2M | 2,542,003 |
| 2025-11-19 | Foresite Capital Management VI LLC 10% owner | Purchase | +190,500 | $6.56 | $1.2M | 2,542,003 |
| 2025-11-19 | Tananbaum James B. Director | Purchase | +190,500 | $6.56 | $1.2M | 2,542,003 |
| 2025-11-18 | AKKARAJU SRINIVAS Director | Purchase | +102,652 | $6.05 | $621K | 379,745 |
| 2025-11-18 | Foresite Labs, LLC 10% owner | Purchase | +117,374 | $6.19 | $727K | 2,351,503 |
Page 4 of 21 · 405 trades